These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 17956498

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda.
    Staedke SG, Sendagire H, Lamola S, Kamya MR, Dorsey G, Rosenthal PJ.
    Trop Med Int Health; 2004 May; 9(5):624-9. PubMed ID: 15117308
    [Abstract] [Full Text] [Related]

  • 23. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
    Djaman AJ, Basco LK, Mazabraud A.
    Sante; 2002 May; 12(4):363-7. PubMed ID: 12626289
    [Abstract] [Full Text] [Related]

  • 24. Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women.
    Tinto H, Ouédraogo JB, Zongo I, van Overmeir C, van Marck E, Guiguemdé TR, D'Alessandro U.
    Am J Trop Med Hyg; 2007 Apr; 76(4):608-13. PubMed ID: 17426157
    [Abstract] [Full Text] [Related]

  • 25. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA, Mahdy MA, Lim YA.
    Malar J; 2015 Dec 22; 14():516. PubMed ID: 26693691
    [Abstract] [Full Text] [Related]

  • 26. Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria.
    Basco LK, Tahar R, Keundjian A, Ringwald P.
    J Infect Dis; 2000 Aug 22; 182(2):624-8. PubMed ID: 10915101
    [Abstract] [Full Text] [Related]

  • 27. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.
    Aubouy A, Jafari S, Huart V, Migot-Nabias F, Mayombo J, Durand R, Bakary M, Le Bras J, Deloron P.
    J Antimicrob Chemother; 2003 Jul 22; 52(1):43-9. PubMed ID: 12805261
    [Abstract] [Full Text] [Related]

  • 28. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
    Dorsey G, Vlahos J, Kamya MR, Staedke SG, Rosenthal PJ.
    J Infect Dis; 2003 Oct 15; 188(8):1231-8. PubMed ID: 14551894
    [Abstract] [Full Text] [Related]

  • 29. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea.
    Mita T, Kaneko A, Hwaihwanje I, Tsukahara T, Takahashi N, Osawa H, Tanabe K, Kobayakawa T, Björkman A.
    Infect Genet Evol; 2006 Nov 15; 6(6):447-52. PubMed ID: 16600696
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E, Kassa M, Taddesse G, Mohammed H, Woyessa A, Tasew G, Sleshi M, Kebede A, Petros B.
    Acta Trop; 2013 Dec 15; 128(3):636-41. PubMed ID: 24055717
    [Abstract] [Full Text] [Related]

  • 31. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S, Kheir A, Abdel-Muhsin AM, Al-Ghazali A, Nwakanma D, Swedberg G, Babiker HA.
    Infect Genet Evol; 2009 Sep 15; 9(5):778-83. PubMed ID: 19379843
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in East Timor.
    Burns M, Baker J, Auliff AM, Gatton ML, Edstein MD, Cheng Q.
    Am J Trop Med Hyg; 2006 Mar 15; 74(3):361-6. PubMed ID: 16525092
    [Abstract] [Full Text] [Related]

  • 33. High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine.
    Zakeri S, Farahani MS, Afsharpad M, Salehi M, Raeisi A, Djadid ND.
    Int J Infect Dis; 2010 Sep 15; 14 Suppl 3():e123-8. PubMed ID: 20399698
    [Abstract] [Full Text] [Related]

  • 34. Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda.
    Sendagire H, Kyabayinze D, Swedberg G, Kironde F.
    Trop Med Int Health; 2005 Jun 15; 10(6):537-43. PubMed ID: 15941416
    [Abstract] [Full Text] [Related]

  • 35. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
    Méndez F, Herrera S, Murrain B, Gutiérrez A, Moreno LA, Manzano M, Muñoz A, Plowe CV.
    Am J Trop Med Hyg; 2007 Sep 15; 77(3):438-43. PubMed ID: 17827356
    [Abstract] [Full Text] [Related]

  • 36. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
    Tessema SK, Kassa M, Kebede A, Mohammed H, Leta GT, Woyessa A, Guma GT, Petros B.
    PLoS One; 2015 Sep 15; 10(10):e0126943. PubMed ID: 26431464
    [Abstract] [Full Text] [Related]

  • 37. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD, van den Broek IV, Kayembe G, Montgomery J, Pota H, Roper C.
    Trop Med Int Health; 2006 Oct 15; 11(10):1503-11. PubMed ID: 17002724
    [Abstract] [Full Text] [Related]

  • 38. Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles.
    Warsame M, Hassan AM, Barrette A, Jibril AM, Elmi HH, Arale AM, Mohammady HE, Nada RA, Amran JG, Muse A, Yusuf FE, Omar AS.
    Trop Med Int Health; 2015 Apr 15; 20(4):510-7. PubMed ID: 25583123
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
    Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum JK, Tsukahara T, Mita T, Takahashi N, Bergqvist Y, Björkman A, Kobayakawa T.
    Acta Trop; 2003 Mar 15; 85(3):363-73. PubMed ID: 12659974
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.